Thermo Fisher Scientific starts senior note saleLas Cruces Sun-NewsOne Lambda's tests are used by transplant centers to determine the compatibility of donors and recipients and detect the presence of antibodies that can lead to transplant rejection…
Thermo Fisher Scientific starts senior note saleSacramento BeeOne Lambda's tests are used by transplant centers to determine the compatibility of donors and recipients and detect the presence of antibodies that can lead to transplant rejection. One…
Thermo Fisher Scientific starts senior note saleThe Associated PressOne Lambda's tests are used by transplant centers to determine the compatibility of donors and recipients and detect the presence of antibodies that can lead to transplant rejectio…
Celebrating Liberal ArtsBucknell UniversityKen Field. Associate professor of biology. "If these drugs are found to specifically block transplant rejection without generally suppressing the immune system, it would be very exciting." › Full s…
XDx, Inc. – Product Pipeline Analysis – New Market Report Now AvailableSBWire (press release)The company discovers, develops and commercializes non-invasive gene expression testing for the monitoring of transplant rejection and autoimmune diseases. Its…
Gulf TimesOrgan donation 'a noble act'Gulf TimesPeople who need an organ transplant often have to wait a long time for the right match as doctors must match donors to recipients to reduce the risk of transplant rejection. The higher the number …
Rigel Announces Second Quarter 2012 Financial ResultsSacramento Bee… with its partner AstraZeneca; R343, an inhaled SYK inhibitor that has completed Phase 1 clinical trials for asthma; R333, a topical JAK/SYK inhibitor for discoid lupus; and R548, an…
Study uses stem cells to boost red blood cell productionMedical XpressResearchers find way to help donor adult blood stem cells overcome transplant rejection created Aug 04, 2011 | popularity not rated yet | comments 0; New research sheds light on how …
Rigel Announces Second Quarter 2012 Financial ResultsEquities.com… with its partner AstraZeneca; R343, an inhaled SYK inhibitor that has completed Phase 1 clinical trials for asthma; R333, a topical JAK/SYK inhibitor for discoid lupus; and R548, an o…
Capitola's Satellite Dialysis fills need for vital serviceSan Jose Mercury NewsFIGHTING REJECTION. Another advance involves drugs such as cyclosporin that can reduce the likelihood of a kidney transplant rejection. Lee Walters, 54, owner of the Sto…